Skip to content
ClinCalc Pro
Menu
Anti-progestogen + prostaglandin (medical abortion)

Mifepristone and misoprostol (combination pack)

Brand names: Mifegyne + Topogyne, MTPak

This is a combination pack pairing the antiprogestogen mifepristone with the prostaglandin analogue misoprostol, used sequentially for medical termination of pregnancy and management of miscarriage.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Mifepristone blocks progesterone receptors, sensitising the myometrium and softening the cervix, after which misoprostol stimulates uterine contractions and cervical ripening to complete expulsion.

Prescribing in practice

  • Mifepristone is taken first and misoprostol after an interval; warn that significant bleeding and cramping are expected and that the woman must have access to urgent care for haemorrhage or signs of incomplete or continuing pregnancy.
  • It should be used within an appropriate provider framework with confirmation of gestation and exclusion of contraindications such as suspected ectopic pregnancy, an in-situ intrauterine device, chronic adrenal failure or severe uncontrolled asthma.
  • If the pregnancy continues after exposure there is a recognised risk of fetal harm, so treatment failure must be actively followed up.

Monitoring

Confirm successful completion clinically or with follow-up testing, and assess bleeding, pain and any signs of infection or retained products.

Counselling the patient

  • Take the mifepristone first, then the misoprostol after the interval your clinician specifies.
  • Heavy bleeding and cramping are expected; seek urgent help for very heavy bleeding, fever, severe pain or feeling faint.
  • Attend any follow-up to confirm the process is complete, and start contraception when advised.

Evidence & guidelines

Sequential mifepristone followed by misoprostol is the regimen recommended by NICE and the RCOG for medical termination and miscarriage management.

Reference: RCOG / NICE NG140; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.